Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18820938rdf:typepubmed:Citationlld:pubmed
pubmed-article:18820938lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C0012655lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C1553355lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C0042900lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C0021745lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C1456820lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C0004083lld:lifeskim
pubmed-article:18820938lifeskim:mentionsumls-concept:C1882417lld:lifeskim
pubmed-article:18820938pubmed:issue1lld:pubmed
pubmed-article:18820938pubmed:dateCreated2008-12-24lld:pubmed
pubmed-article:18820938pubmed:abstractTextVitiligo is a common skin disorder that is caused by selective destruction of melanocytes, resulting in disfiguring loss of pigment. There are convincing evidences that cytokines and T cell mediated immunity may have a role in its pathogenesis. Given the fact that cytokine production is under genetic control, in this study, we have investigated IFN-gamma +874 T/A and TNF-alpha -308 G/A gene polymorphisms in a total of 176 vitiligo patients and 545 controls. IFN-gamma +874 T/A and TNF-alpha -308 G/A gene polymorphisms were genotyped via Allele Specific Oligonucleotide PCR (ASO-PCR) method. The results showed that the TNF-alpha -308 G/A polymorphism was more common in vitiligo patients than controls (P = 0.0004). This difference was only significant between female patients and controls (P < 0.0001), while there was no significant difference between male patients and male controls (P = 0.90). The distribution of IFN-gamma genotypes in vitiligo patients did not differ significantly from that in control subjects (P = 0.56). Since the presence of A nucleotide at position -308 of TNF-alpha gene is associated with increased cytokine production, therefore, the higher frequency of TNF-alpha -308 A allele in vitiligo patients compared to controls may be considered as a genetic susceptibility factor towards the development of vitiligo.lld:pubmed
pubmed-article:18820938pubmed:languageenglld:pubmed
pubmed-article:18820938pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18820938pubmed:citationSubsetIMlld:pubmed
pubmed-article:18820938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18820938pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18820938pubmed:statusMEDLINElld:pubmed
pubmed-article:18820938pubmed:monthJanlld:pubmed
pubmed-article:18820938pubmed:issn1432-069Xlld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:Kamali-Sarves...lld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:NamianAli-Moh...lld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:ShahbazShimaSlld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:SalmanpoorRah...lld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:NamaziMohamma...lld:pubmed
pubmed-article:18820938pubmed:authorpubmed-author:DehghaniFarid...lld:pubmed
pubmed-article:18820938pubmed:issnTypeElectroniclld:pubmed
pubmed-article:18820938pubmed:volume301lld:pubmed
pubmed-article:18820938pubmed:ownerNLMlld:pubmed
pubmed-article:18820938pubmed:authorsCompleteYlld:pubmed
pubmed-article:18820938pubmed:pagination21-5lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:meshHeadingpubmed-meshheading:18820938...lld:pubmed
pubmed-article:18820938pubmed:year2009lld:pubmed
pubmed-article:18820938pubmed:articleTitleAssociation of interferon-gamma and tumor necrosis factor alpha polymorphisms with susceptibility to vitiligo in Iranian patients.lld:pubmed
pubmed-article:18820938pubmed:affiliationDepartment of Dermatology, Medical School, Shiraz University of Medical Sciences, Shiraz, Iran.lld:pubmed
pubmed-article:18820938pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:18820938pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:3458entrezgene:pubmedpubmed-article:18820938lld:entrezgene
entrez-gene:7124entrezgene:pubmedpubmed-article:18820938lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18820938lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18820938lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18820938lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:18820938lld:entrezgene